Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by Chopper1BigDogon Feb 17, 2021 3:18am
158 Views
Post# 32581977

MiQLab

MiQLab What separates MiQLab from current
automated RT-PCR solutions such as GenMark, Cepheid, BioFire... there are many unique features & benefits: 

- Lexagene has designed MiQLab to be the most versatile automated RT-PCR solution. Lex is targeting many industries Food, Vet, Human, Open Access, Water, Pharma, Research.... not just human diagnostics like most competitors
- Open Access vs competitors closed access systems. Open Access allows for custom tests to be run on MiQLab. This is essential for many use cases and industries. Competitors utilize closed access systems that have expensive embedded cartridges (reagents inside). MiQLab is a microfluidic device (reagents are inside the machine not in the cartridge) this is a huge advantage. For example, detecting new Covid strains, that can be done within days of sequencing. Closed Access systems take months to manufacture embedded cartridges to do this. 
- Cost/Test is by far the lowest, approx 1/10th vs competitors. This is a result of the microdfluidic design and the fact MiQLab uses empty cartridges and not expensive embedded cartridges. This allows Lex to target high throughput industries such as food and water...
- Quantitative vs Qualitative, MiQLab provides quantitative results. Results provide the level of an infection not just yes/no results. This is essential for many use cases and industries.
- Ease of use, anybody can operate. Less than 1 minute to load a test. No tech required
- Point of care solution, due to the ease of use and automated sample prep MiQLab can be used at the point of care/need
- Sample Size, MiQLab allows for samples up to 50,000ul vs competitors 500ul. This is essential for many industries such as food, water...
- sensitivity and gold standard results, MiQLab’s method of detection probe based qPCR and the sample prep method is sonication, chemical lysis, silica frit, RT-PCR devices use diffferent methods
<< Previous
Bullboard Posts
Next >>